The mechanism of differential Bcl-2 protein expression in breast cancer is not fully elucidated, and understanding the mechanisms regulating Bcl-2 family protein expression in ER+ breast cancer could benefit treatment options. The gene discussed is BCL2; the disease is breast carcinoma.